Pathology, genetics and cytogenetics of Wilms' tumour

Pathology. 2011 Jun;43(4):302-12. doi: 10.1097/PAT.0b013e3283463575.

Abstract

Wilms' tumour (WT) is an embryonal cancer of childhood and is thought to be derived from embryonic kidney precursor cells. The Knudson two hit model was initially thought to occur in WT, but findings emerging from genetic and cytogenetic studies in the past two decades have implicated several genetic events. Recent techniques in genetic analysis have improved our ability to characterise changes in genes involved in WT which include WT1, CTNNB1, IGF2 and WTX. These genetic events have not only provided insight into the pathobiology of this malignancy, but the recognition of these candidate genes may offer potential targets for novel therapies. In this review, we will provide an overview of the pathological, genetic and cytogenetic characteristics of WT.

Publication types

  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adolescent
  • Child
  • Child, Preschool
  • Cytogenetics
  • Genes, Wilms Tumor*
  • Humans
  • Infant
  • Insulin-Like Growth Factor II / genetics
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / pathology*
  • Tumor Suppressor Proteins / genetics
  • WT1 Proteins / genetics
  • Wilms Tumor / genetics
  • Wilms Tumor / pathology*
  • beta Catenin / genetics

Substances

  • AMER1 protein, human
  • Adaptor Proteins, Signal Transducing
  • CTNNB1 protein, human
  • Tumor Suppressor Proteins
  • WT1 Proteins
  • beta Catenin
  • Insulin-Like Growth Factor II